CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
-4.45%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(+11%)
Cap. Flow
+$48.7M
Cap. Flow
% of AUM
18.62%
Top 10 Holdings %
Top 10 Hldgs %
82.88%
Holding
26
New
4
Increased
13
Reduced
1
Closed
–
Top Buys
| 1 |
Kezar Life Sciences
KZR
|
$12.6M |
| 2 |
INZY
Inozyme Pharma
INZY
|
$5.45M |
| 3 |
Nkarta
NKTX
|
$4.41M |
| 4 |
Precision BioSciences
DTIL
|
$3.84M |
| 5 |
Cullinan Oncology
CGEM
|
$3.78M |
Top Sells
| 1 |
ONCR
Oncorus, Inc.
ONCR
|
$63K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|